Budget Impact Analysis of CYP2C19 Genotyping to Target Voriconazole Prophylaxis During Induction-Consolidation Therapy in Acute Myeloid Leukemia (AML) in The United States
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2203
https://www.valueinhealthjournal.com/article/S1098-3015(14)04133-3/fulltext
Title :
Budget Impact Analysis of CYP2C19 Genotyping to Target Voriconazole Prophylaxis During Induction-Consolidation Therapy in Acute Myeloid Leukemia (AML) in The United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04133-3&doi=10.1016/j.jval.2014.08.2203
First page :
A621
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1661